Egetis Therapeutics Q4’21: Exciting times ahead - Redeye
Redeye leaves a comment on the Q4 report from Egetis Therapeutics released earlier this morning. While the report did not include any significant surprises, it summarizes an exciting quarter for the company.
ANNONS
Redeye leaves a comment on the Q4 report from Egetis Therapeutics released earlier this morning. While the report did not include any significant surprises, it summarizes an exciting quarter for the company.